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Abstract
Previous studies of triclocarban suggest that its biotransformation could yield reactive metabolites
that form protein adducts. Since the skin is the major route of triclocarban exposure, present work
examined this possibility in cultured human keratinocytes. The results provide evidence for
considerable biotransformation and protein adduct formation when cytochrome P450 activity is
induced in the cells by TCDD, a model Ah receptor ligand. Since detecting low adduct levels in
cells and tissues is difficult, we utilized the novel approach of accelerator mass spectrometry for
this purpose. Exploiting the sensitivity of the method, we demonstrated that a substantial portion
of triclocarban forms adducts with keratinocyte protein under the P450 inducing conditions
employed.
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INTRODUCTION
Triclocarban (TCC) is a common antimicrobial preservative in personal care products,
particularly in bar soaps. Human exposure to TCC has come to public attention because it
accumulates in the aquatic environment [1] and has biological effects on mammals. TCC is a
potent inhibitor (IC50 24 ± 5 nM) of the human soluble epoxide hydrolase, an enzyme of the
arachidonic cascade [2-4]. Similarly potent inhibitors have pronounced pharmacological
effects on regulation of inflammation and pain [5]. Moreover, TCC may act as an endocrine
disruptor at high concentration by enhancing the action of testosterone [6].
Bathing with TCC-containing soaps typically results in deposition of TCC on human skin of
≈0.3 μg/cm2 [7]. A substantial portion traverses the epidermal barrier, is absorbed and
becomes systemically available [4, 8]. During showering with antibacterial soap, ≈0.6% of
the applied amount of TCC is dermally absorbed and is detected almost exclusively as
metabolites [4]. In the plasma of mammals, TCC is found primarily as its sulfated oxidative
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metabolites, particularly 2′-SO3-O-TCC. In the bile, glucuronic acid conjugates of
hydroxylated metabolites dominate, and in human monkey and mouse urine primarily N-
glucuronides are excreted [9, 10]. Thus, both oxidative phase I metabolism, catalyzed by
cytochrome-P-450 monooxygenases, and phase II metabolism, catalyzed by
sulfotransferases and UDP-glucuronlytransferases, are important. Since keratinocytes in the
epidermis and in culture express substantial phase I and phase II activities [11, 12], this
work explores the hypothesis that, upon dermal exposure, TCC undergoes biotransformation
that produces potentially deleterious reactive metabolites. Use of accelerator mass
spectrometry (AMS) offers the possibility to detect protein adducts of such metabolites with
much greater sensitivity than with other methods [13-15].
MATERIALS AND METHODS
Generation and Analysis of Metabolites in Cell Culture
Human epidermal spontaneously immortalized keratinocytes (SIK) were cultured with
feeder layer support in a DMEM-Ham’s F-12 mixture (2:1) as previously described [16].
For metabolite identification, near-confluent cultures were treated with or without 10 nM
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for one day before addition of 2 μM TCC
(1:1000 dilution of a 2 mM stock solution in DMSO). After 10 min or 20 h incubation,
cultures were rinsed in 0.15 M sodium chloride - 10 mM sodium phosphate (pH 7.2),
drained, recovered by scraping from the dishes in 0.5 ml of 10 mM Tris (pH 8) - 1 mM
EDTA, sonicated and stored at -80°C in two equal aliquots. 50 μL of the homogenate were
mixed with 200 μL of acetonitrile/acetic acid (99/2 v/v) containing 12.5 nM 13C6-TCC as
internal standard and analyzed directly by online-SPE-LC-MS as previously described [17].
The second aliquot was dissolved in 2% SDS for protein assay using bicinchoninic acid
(BCA, Pierce Chem Co, Rockford IL). For determination of protein binding, cells were
incubated for 3, 8 and 24 h with 2 μM [14C]TCC (specific activity 0.04 Ci/mol), rinsed
twice with phosphate buffered saline, dissolved in 2% SDS containing 25 mM DTE, and
sulfhydryls were alkylated with iodoacetamide. The protein was isolated by Sephadex G-25
gel filtration in 0.1% SDS and precipitated by addition of 2.5 vol of ethanol. The pellet was
rinsed 3X in 67% ethanol and then analyzed for 14C content.
AMS Analysis
Each protein pellet was placed in a quartz tube (~6×30 mm, 4 mm i.d.) nested inside two
borosilicate glass culture tubes (10×75 mm in 12×100 mm) and dried overnight in a vacuum
centrifuge. An excess of CuO (≈40 mg) was added and the inner quartz vials were
transferred to quartz combustion tubes, evacuated and sealed. The samples were combusted
at 900°C for 3.5 h to oxidize completely all carbon to CO2 and then reduced to filamentous
carbon as previously described [18]. Carbon samples were packed into aluminum sample
holders, and carbon isotope ratios were measured on the compact 1-MV AMS spectrometer
at the Lawrence Livermore National Laboratory centered around a National Electrostatics
Corporation 3SDH-1 accelerator [19]. Typical AMS measurement times were 3-5 min/
sample, with a counting precision of 0.8 – 1.4 % and a standard deviation among 3-7
measurements of 1-3%. The 14C/13C ratios of the unknowns were normalized to
measurements of four identically prepared standards of known isotope concentration
(Australian National University Sucrose) and converted to units of pmol TCC/mg protein
[20].
RESULTS
TCC was rapidly absorbed by the epidermal cells. After 10 min, the intracellular TCC
concentration reached 1.21 ± 0.27 nmol/mg protein and increased by 20 h incubation to a
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level of 2.04 ± 0.27 nmol/mg protein. LC-MS/MS analysis revealed that a small portion of
the absorbed TCC was metabolized by SIK. After 24 h, 4.6 ± 1.6 pmol/mg protein 2′OH-
TCC was found, along with lower concentrations of the other known mono-hydroxylated
TCC metabolites, 3′OH-TCC (1.9 ± 0.7 pmol/mg protein) and 6-OH-TCC (0.4 ± 0.7 pmol/
mg protein). The glucuronide of 2′OH-TCC was the second most abundant detected
metabolite (Figure 1). Preincubation with 10 nM TCCD dramatically augmented metabolism
of TCC in the keratinocytes, and the relative conversion (cellular metabolite concentration
versus cellular TCC concentration) increased from ≈ 0.5 % to 15% (Figure 1). In line with
previous findings that TCC is not an AhR agonist [21], this finding indicates that the CYP
isoforms responsible for TCC metabolism (likely CYP1A1 and CYP1B1) are inducible by
AhR agonists but are not well induced by TCC alone. After TCDD induction, unconjugated
2′OH-TCC remained the major metabolite with a concentration of 165 ± 28 pmol/mg
protein, far exceeding the concentration of its conjugates. At 5.91 ± 28 pmol/mg protein, the
recently described oxidative metabolite 3,4-dichloro-4’-hydroxy-carbanilide (DHC) [22]
was also formed in substantial amounts. 2′-SO3-O-TCC levels were <1 pmol/mg protein,
suggesting that 2′OH-TCC is a poor substrate for the major sulfotransferase (SULT2B1b)
reported in epidermis [11] and expressed in SIK [16]. Additionally, formation of 6-OH-
Gluc-TCC was detected, whereas no evidence for direct glucuronidation of TCC to the
major urine N-glucuronide metabolites of TCC [4] was found.
Since TCC can be metabolized in epidermal keratinocytes, it is anticipated to be
biotransformed during dermal absorption from personal care products. The observed
metabolites are consistent with those detected in mammals with 2′OH-TCC as the major
oxidative metabolite [9]. By contrast to the metabolite patterns in blood, bile and urine, the
amount of unconjugated oxidative metabolites of TCC exceeded by far the level of
conjugated (phase II) species. Nearly two fold more 2′OH-TCC was formed than 2′-Gluc-
O-TCC with or without TCCD pretreatment (Figure 1). Because further oxidation of 2′OH-
TCC can yield a reactive quinone-imine [22], we hypothesized that TCC metabolism in
keratinocytes can lead to protein adduct formation. As shown in Figure 2, up to 23 ± 2 pmol
TCC adducts/mg protein were detected after 24 h incubation in the presence of TCDD. As
illustrated, protein adducts increased in a time dependent manner, but only very low adduct
formation of about 1 pmol/mg protein, slightly above the background signal, was detected in
the absence of TCDD, in line with the low metabolic conversion of TCC (Fig 1).
DISCUSSION
This study demonstrates that TCC oxidative conversion leads to reactive intermediates that
can bind covalently to protein, a phenomenon clearly manifest upon induction of
metabolizing enzymes. It is noteworthy that the low level of TCC adducts produced a
substantial 14C signal, which was only ≈ 20x fold higher than the natural 14C/C
concentration of 1.2×10-12. Due to the high sensitivity of AMS, quantitative information
about very low protein adducts of TCC can be obtained enabling investigation of their
formation mechanistically. The relatively low protein adduct formation of TCC and high
sensitivity of AMS are well suited for obtaining quantitative information on the distribution
of protein adducts in vivo, especially if individual proteins are isolated to identify specific
targets.
Human epidermal cells cultured in the Rheinwald-Green system provide a close
approximation to natural epidermis [23]. The SIK line, a minimally deviated epidermal
model, has been utilized previously to demonstrate the importance of CYP induction to
produce toxic effects of agents that are themselves poor inducers [24]. The reactivity of a
chemical to produce a complete antigen by covalently adducting carrier protein is the major
factor in producing allergic skin sensitization [25]. Among the numerous compounds for
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which the importance of epidermal cytochrome P450 activity is known to activate non-
reactive chemicals is the common rubber constituent and known sensitizer diphenylthiourea
[26]. In the absence of P450 induction, the low level of TCC-protein adducts suggests only a
low probability of adverse effects in keratinocytes. However, the substantial level of protein
adducts with TCDD treatment raises the possibility of skin sensitization in special
circumstances. P450 inducers such as Ah receptor agonists [27], for which TCDD in this
work serves as a proxy, are widely encountered in tobacco smoke, pharmaceuticals, food
constituents and other consumer products, as well as in environmental pollutants, and even
from the skin microflora [28]. The unrecognized possibility that TCC, with wide human
exposure to the integument, contributes to the burden on society of allergic contact
dermatitis or other toxic effects, particularly in individuals exposed to ubiquitous Ah
receptor agonists, merits further investigation. Moreover, in view of the ability of
Langerhans cells to participate in activation of chemicals in the epidermis [29], present work
could underestimate the risk posed by TCC.
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FIGURE 1.
TCC biotransformation by human keratinocytes. Parallel SIK cultures pretreated one day ±
10 nM TCDD as indicated were then treated for 20 hr with 2 μM TCC. The metabolite
levels detected were normalized to protein concentration (3.6 ± 0.4 mg/ml without TCDD;
4.1 ± 0.3 mg/ml after TCDD treatment). DHC, 3,4-dichloro-4’-hydroxy-carbanilide. Each
experiment was conducted in triplicate, and values are presented as means ± SD.
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FIGURE 2.
Covalent protein adduct formation by TCC (2 μM) in spontaneously immortalized
keratinocytes (SIK) determined by accelerator mass spectrometry. A background value of
0.5 pmol/mg (0.5 h incubation without TCDD induction) has been subtracted. Each
experiment was conducted in triplicate and values are presented as means ± SD.
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